Oxford Pharmascience Group

Oxford Pharmascience is a drug development company that re-develops approved drugs using proprietary formulation technologies to make them better, safer and easier to take. Since Oxford Pharmascience's products incorporate previously approved drugs, this reduces risk and results in a simplified drug development regulatory pathway allowing less expensive development programs and faster access to market. The Company's pipeline is focused on cardiovascular disease and pain relief indications addressing unmet patient needs with significant commercial potential in global markets. The company was founded in February'08 and floated in London's AIM market in February 2010.
Company Growth (employees)
London, GB
Size (employees)
10 (est)
Oxford Pharmascience Group was founded in 2008 and is headquartered in London, GB

Oxford Pharmascience Group Office Locations

Oxford Pharmascience Group has an office in London
London, GB (HQ)
2 Royal College Street, Camden

Oxford Pharmascience Group Data and Metrics

Oxford Pharmascience Group Financial Metrics

Oxford Pharmascience Group's revenue was reported to be £749 k in FY, 2015 which is a 6% increase from the previous period.
Numbers are in £, GBP

Revenue (FY, 2015)

749 k

Revenue growth (FY, 2014 - FY, 2015), %


Gross profit (FY, 2015)

158 k

Gross profit margin (FY, 2015), %


Net income (FY, 2015)

(3.1 m)

Market capitalization (26-May-2015)

253.2 b

Closing share price (26-May-2015)


Cash (31-Dec-2015)

13.1 m
Oxford Pharmascience Group's current market capitalization is $253.2 b.
Numbers are in £, GBPFY, 2013FY, 2014FY, 2015


1 m705 k749 k

Revenue growth, %


Cost of goods sold

693 k482 k591 k

Gross profit

336 k223 k158 k

Gross profit Margin, %


Operating expense total

1.9 m3.7 m4.1 m

Pre tax profit

(1.5 m)(3.5 m)(3.9 m)

Net Income

(1.5 m)(2.9 m)(3.1 m)
Numbers are in £, GBPFY, 2013FY, 2014FY, 2015


9.9 m6.7 m13.1 m

Accounts Receivable

108 k215 k179 k

Current Assets

10.2 m7.6 m24.1 m


5 k5 k4 k


51 k43 k34 k

Total Assets

10.3 m7.6 m24.1 m

Accounts Payable

240 k223 k167 k

Current Liabilities

370 k292 k307 k

Retained Earnings

(1.5 m)(2.9 m)(3.1 m)

Total Equity

9.9 m7.3 m23.8 m

Financial Leverage

1 x1 x1 x
Numbers are in £, GBPFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

(1.2 m)(3.4 m)(3.2 m)

Cash From Financing Activities

8.9 m157 k19.4 m

Income Taxes Paid

49 k600 k763 k
Numbers are in £, GBPY, 2015


71.3 k

Financial Leverage

1 x

Oxford Pharmascience Group Company Life and Culture

You may also be interested in